Can genetics predict bothersome hot flashes? New study suggests that some of the same genetic variants that help to predict reproductive aging are associated with frequency and severity of hot flashes CLEVELAND, Ohio (April 28, 2021)--Hot flashes are a ha ...
Why it matters that COVID viruses are losing parts of their genome Again and again, the new coronavirus has sloughed off small chunks of its genome, leading to changes in a viral protein that is frequently targeted by antibodies. When evolution sni ...
Pediatric Minority Patients Less Likely to Undergo ED Imaging Significant racial and ethnic differences in diagnostic imaging rates exist among children receiving care in pediatric EDs across the United States, Jennifer R. Marin, MD, of the University ...
Intranasal influenza vaccine spurs strong immune response in Phase 1 study What An experimental single-dose, intranasal influenza vaccine was safe and produced a durable immune response when tested in a Phase 1 study published in the Journal o ...
NIH researchers identify new genetic disorder that affects the brain, craniofacial skeleton Researchers at the National Institutes of Health have discovered a new genetic disorder characterized by developmental delays and malformations of the brain, h ...
What's the Best Second-Line Drug Class for Type 2 Diabetes? Sodium-glucose cotransporter 2 (SGLT2) inhibitors to treat type 2 diabetes appear to confer greater cardiovascular benefit than glucagon-like peptide-1 (GLP-1) receptor agonists amo ...
Remote patient monitoring poised for further growth in clinical trials Remote patient monitoring (RPM) is among the trends that will have the greatest impact on the pharma sector in 2021, according to the recent report, “The State of the Biopharma ...
FDA signs off on drug to support prostate cancer imaging The FDA has approved Gallium 68 PSMA-11 for patients having prostate cancer imaging who are potentially treatable with surgery or radiation therapy. The approval also covers patients with sus ...
Nivolumab Improves Survival in Relapsed Mesothelioma In the first ever placebo-controlled phase 3 trial in patients with relapsed mesothelioma, immunotherapy with nivolumab (Opdivo) significantly improved both overall survival (OS) and progressio ...
How gut microbes could drive brain disorders Scientists are starting to work out how the gut microbiome can affect brain health. That might lead to better and easier treatments for brain diseases In 2006, soon after she launched her own laboratory, ...
